Practice Patterns in the Treatment and Monitoring of Acute T Cell–Mediated Kidney Graft Rejection in Canada
Background: One of the goals of the Canadian National Transplant Research Program (CNTRP) is to develop novel therapies for acute rejection that could positively affect graft outcomes with greater efficacy or less toxicity. To develop innovative management strategies for kidney graft rejection, new...
Main Authors: | Julie Leblanc, Peter Subrt, Michèle Paré, David Hartell, Lynne Sénécal, Tom Blydt-Hansen, Héloïse Cardinal |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-02-01
|
Series: | Canadian Journal of Kidney Health and Disease |
Online Access: | https://doi.org/10.1177/2054358117753616 |
Similar Items
-
Coagulation and Fibrinolysis in Kidney Graft Rejection
by: Giovanni Stallone, et al.
Published: (2020-08-01) -
Hyperacute Rejection of a Living Unrelated Kidney Graft
by: Dietlind Tittelbach-Helmrich, et al.
Published: (2014-01-01) -
FEATURES OF PLASMAPHERESIS IN THE TREATMENT OF GRAFT REJECTION AFTER KIDNEY TRANSPLANTATION
by: A. V. Vatazin, et al.
Published: (2015-10-01) -
Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection
by: Gunilla Einecke, et al.
Published: (2018-01-01) -
Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
by: O. N. Rzhevskaya, et al.
Published: (2018-08-01)